Elston George — SEC Form 4 filings

SEC reporting owner CIK 1429932. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-01-09 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EyePoint, Inc. (EYPT)Chief Financial Officer1351

Form 4 filings — Elston George

FiledFormIssuerReported transactionsSource
2026-08-244EyePoint, Inc. (EYPT)Other (J): 5,000 @ $0 · Other (J): 5,000 @ $0 · Gift (G): 64,953 @ $0 · Gift (G): 64,953 @ $0EDGAR
2026-05-274EyePoint, Inc. (EYPT)Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,627 @ $12.93 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2026-03-064EyePoint, Inc. (EYPT)Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0EDGAR
2026-01-074EyePoint, Inc. (EYPT)Option exercise (M): 15,285 @ $0 · Tax withholding (F): 4,487 @ $16.86 · Option exercise (M): 15,285 (derivative) @ $0EDGAR
2026-01-064EyePoint, Inc. (EYPT)Option exercise (M): 19,667 @ $0 · Tax withholding (F): 6,324 @ $17.48 · Option exercise (M): 15,000 @ $0 · Tax withholding (F): 4,403 @ $17.43 · Grant/award (A): 63,000 (derivative) @ $0 · Grant/award (A): 126,000 (derivative) @ $0 · +2 moreEDGAR
2025-12-234EyePoint, Inc. (EYPT)Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0EDGAR
2025-09-224EyePoint Pharmaceuticals, Inc. (EYPT)Gift (G): 20,000 @ $0 · Gift (G): 20,000 @ $0EDGAR
2025-05-274EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 7,500 @ $0 · Tax withholding (F): 2,202 @ $5.68 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2025-02-114EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 5,834 @ $0 · Option exercise (M): 5,834 (derivative) @ $0EDGAR
2025-01-074EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 15,000 @ $0 · Tax withholding (F): 5,267 @ $8.26 · Option exercise (M): 15,285 @ $0 · Tax withholding (F): 4,808 @ $8.68 · Grant/award (A): 59,000 (derivative) @ $0 · Grant/award (A): 117,000 (derivative) @ $0 · +2 moreEDGAR
2024-05-284EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,627 @ $11.16 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2024-02-134EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 4,967 @ $0 · Option exercise (M): 5,833 @ $0 · Tax withholding (F): 1,734 @ $28.80 · Tax withholding (F): 1,458 @ $28.80 · Option exercise (M): 4,967 (derivative) @ $0 · Option exercise (M): 5,833 (derivative) @ $0EDGAR
2024-01-094EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 15,285 @ $0 · Tax withholding (F): 4,911 @ $20.40 · Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Option exercise (M): 15,285 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1429932 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →